CLINICAL_TRIALS
trial_result
· 2013-10-29
Clinical Trial Update: Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study [Phase 3]
Summary
Phase 3 long-term safety study of Fluticasone Furoate/GW642444 inhalation powder in asthma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2013-10-29